2023 annual financial data
Eton Pharmaceuticals 2023 Operating margin
Eton Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -3.77%.
Operating income was -1,192,000 USD and net income was -936,000 USD.
Operating cash flow was 6,815,000 USD.
Get free Eton Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,642,000 USD
- Operating income
- -1,192,000 USD
- Net income
- -936,000 USD
- Operating cash flow
- 6,815,000 USD